|Current status of Dolutegravir?
Mar 28, 2014
Hi Dr. Young. Could you tell me what the current status of Dolutegravir is? The last I heard it was in Phase III testing. I am currently using Isentress with no problems, but I understand that Dolutegravir is much more potent and less toxic. Will it be available soon?
Response from Dr. Young
Dolutegravir (Tivicay) was FDA approved in the US last summer. In first-line therapy, Tivicay and Isentress performed identically (search for the Spring-2 study); in second-line treatment for people with drug resistant virus, Tivicay appears to be more potent virologically.
The toxicity profiles of the two drugs are very similar.
Hope that helps. BY
Early Initiation of HAART 12 weeks after Exposure
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.